An undercover investigation has revealed that unlicensed weight loss drugs, nicknamed the "Godzilla jab," are being sold across social media by various professionals. These substances, including the potent retatrutide, are being marketed for "research use only" to circumvent UK medical regulations.

Advertisement

The surge in demand for next-generation obesity medications

The rapid rise of next-generation obesity treatments has created a high-stakes shadow economy of unlicensed drug sales. As Eli Lilly devleops retatrutide—a drug that clinical trial results suggest can help users lose up to a third of their body weight—a black market has emerged to capitalize on the intense social media hype.

This trend mirrors the explosive popularity of established medications like Ozempic and Mounjaro, but with a significantly more dangerous and unregulated twist. Unlike these licensed treatments, the "Godzilla jab" is being peddled by a diverse range of individuals , from personal trainers to high-flying businesswomen, often bypassing the safety oversight required for human consumption.

Sheryl Cuisia and the £55 "Research" Loophole

Sheryl Cuisia, a 48-year-old entrepreneur linked to King's College, Cambridge, exemplifies the new face of the weight loss drug trade. according to the Daily Mail report, Cuisia sold a five-week supply of retatrutide to an undercover reporter for £55, claiming the substance was intended for "research use only." This specific disclaimer is a common tactic used by dealers to exploit legal loopholes, even though the drug is being actively promoted for human weight loss.

Cuisia, who lives in a riverside penthouse in east London, admitted to using a dozen different drugs herself.. While she described retatrutide as one of the most promising obesity medicines in development, her business model relies on a "research" label that does not reflect the actual intended use of the product.

The 350-Ton Capacity of Chinese Production Facilities

Massive industrial-scale laboratories in China are fueling the global demand for these bootleg weight loss chemicals. An undercover investigation found a 15 ,000 square meter facility that includes eight workshops and four warehouses dedicated to chemical processing. This facility boasts an annual production capacity of up to 350 tons, allowing it to ship hundreds of thousands of pounds worth of weight loss drugs to the UK every month.

The economics of this trade provide a massive incentive for UK-based resellers. For instance, a wholesale price list showed that 70 vials of 10mg retatrutide could be purchased for approximately $700. If a reseller sells those same vials to UK customers at £55 each,they could realize a profit of more than £3,000 on a single purchase.

From School Gates to Soho House: The Social Media Spread

The distribution of these drugs has moved beyond traditional black markets and into respectable social circles. Personal trainers are reportedly dispensing retatrutide to clients in gyms, while middle-class mothers are allegedly trading boxes of the substance outside school gates. This shift is driven by social media hype, where the promise of rapid weight loss outweighs the warnings from medical experts.

This phenomenon is turning professionals—including "gym bros" and "bio hackers"—into unlicensed distributors of potentially dangerous chemicals. The social pressure to achieve specific physical results has created a culture where the legality and safety of a substance are secondary to its perceived efficacy.

The MHRA’s Warning on Unlicensed Retatrutide

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued clear warnings regarding the use of these unlicensed substances. While the act of buying or possessing these substances may not be an offense, the MHRA stated that they disregard "research purposes" claims if it is clear the label is being used to avoid medicines regulations.

Because retatrutide is not yet licensed for human use in the UK, the substances being sold via social media carry significant, unverified health risks. Medical experts fear that the warnings regarding these bootleg versions, which are likely made in industrial Chinese labs, are being drowned out by the allure of the "miracle" drug.

The Mystery of Archangel Labs and Vetted Vendors

Significant questions remain regarding the legitimacy of the supply chain used by these social media dealers. While Cuisia’s website identifies Archangel Labs as her supplier, the Daily Mail reported that no evidence of this company's existence could be found. This lack of transparency makes it impossible for consumers to know the true origin or purity of the drugs they are injecting.

Furthermore, while Cuisia claimed to use four to five "vetted vendors ," the safety standards of these sources remain entirely unverified. The discrepancy between the sleek, professional websites used by these sellers and the reality of their anonymous, unverified supply chains represents a major public health concern.